Michelle Mersmann
Family · Greenville, TXNPI 1912391103
Payments from drug & device makers
Across 171 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$579
- Novo Nordisk$394
- Pfizer$389
- Currax Pharmaceuticals LLC$281
- Lilly USA, LLC$240
- Astellas Pharma US Inc$185
- plus $659 from 13 others
What the payments were for
- Food & beverage$2,62896%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $579 |
| Novo Nordisk | 19 | $394 |
| Pfizer | 24 | $389 |
| Currax Pharmaceuticals LLC | 35 | $281 |
| Lilly USA, LLC | 15 | $240 |
| Astellas Pharma US Inc | 6 | $185 |
| AstraZeneca | 8 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $104 |
| Boehringer Ingelheim | 3 | $60 |
| GSK | 4 | $59 |
| Exact Sciences | 2 | $45 |
| IBSA Pharma Inc. | 3 | $45 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Genentech USA, Inc. | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$113
How this compares
$2,727 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 30 | $1,195 |
| Bupropion XlBupropion Hcl | 20 | $622 |
| Montelukast Sodium | 15 | $255 |
| Levothyroxine Sodium | 30 | $245 |
| Losartan Potassium | 22 | $136 |
| Rosuvastatin Calcium | 17 | $120 |
| Lisinopril | 12 | $114 |
| Metformin Hcl | 16 | $97 |
| Amlodipine Besylate | 13 | $85 |
| Atorvastatin Calcium | 20 | $81 |
| Simvastatin | 19 | $80 |
| Metformin Hcl ErMetformin Hcl | 20 | $63 |
| Escitalopram Oxalate | 12 | $50 |
| Hydrochlorothiazide | 11 | $5 |
Paid to pharmacies, not to this prescriber.
Other family in Greenville
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.